Streetbeat News

Stock Prices

SQM

Sociedad Quimica Y Minera's (SQM) shares are trading lower after Bank of America Securities downgraded the stock from Neutral to Underperform and set a price target of $59.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:41 pm

WIT

Wipro reported lower than expected Q2 sales results and issued guidance, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:39 pm

NUZE

NuZee, Inc. (NASDAQ: NUZE), a coffee co-packing and technology company, has priced its underwritten public offering of 425,000 shares of its common stock at $3.00 per share. The offering is expected to generate gross proceeds of approximately $1.275 million. The public offering is expected to close on October 20, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:37 pm

PG

Procter & Gamble Co (NYSE:PG) reported Q1 FY24 sales growth of 6.1% YoY to $21.87 billion, beating the consensus of $21.67 billion. Organic sales increased 7%, driven by higher pricing and favorable product mix. Adjusted EPS of $1.83 beat the consensus of $1.71. The company returned $3.8 billion of cash to shareholders via dividend payments and stock repurchases. P&G now sees all-in sales growth of 2%-4% and maintains FY24 organic sales growth expectation of 4%-5%. The company expects to pay over $9 billion in dividends and repurchase $5 billion-$6 billion of common shares in fiscal 2024.

Portfolio Pulse from Akanksha Bakshi

October 18, 2023 | 12:37 pm

SPY

USA Housing Starts for September increased by 7.0%, a significant improvement from the prior month's decrease of 12.5%.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:31 pm

SPY

USA Housing Starts for September were reported at 1.358M, lower than the estimated 1.380M and higher than the prior figure of 1.269M.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:30 pm

ARDX

The FDA has approved Ardelyx Inc's (NASDAQ:ARDX) kidney disease-related drug, Xphozah, after initially rejecting it. The drug is the first and only phosphate absorption inhibitor, designed to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx has also amended its debt financing agreement with SLR Capital Partners, gaining access to an additional $50 million in committed debt financing. ARDX shares are up 16.20% premarket.

Portfolio Pulse from Vandana Singh

October 18, 2023 | 12:29 pm

RFAC

GCL Asia, a leading video game distribution and publishing group in Asia, is set to go public via a merger with RF Acquisition Corp. The combined company will be listed on Nasdaq under the ticker symbol 'GCL'. The proposed transaction gives GCL approximately $1.2 billion in pre-transaction equity value. GCL's shareholders will retain a majority of the combined company's outstanding shares. The transaction is expected to close in the second quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:28 pm

SHW

B of A Securities analyst Steve Byrne has downgraded Sherwin-Williams (NYSE:SHW) from Neutral to Underperform and lowered the price target from $300 to $275.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 12:26 pm

ABBV

TAK

Takeda Pharmaceutical's (TAK) Phase 3 ADMIRE-CD II study for Alofisel, a treatment for complex Crohn's Perianal Fistulas, did not meet its primary endpoint. The company also settled a tax dispute with the Irish Revenue Commissioners related to a break fee received by Shire plc from AbbVie (ABBV) in 2014. Takeda's shares fell 1.47% in premarket trading.

Portfolio Pulse from Vandana Singh

October 18, 2023 | 12:25 pm